Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith C Ferdinand

Showing results (231-240 of 287) with videos related to

Pageof 29
Sort By:
Journal of Clinical Lipidology|March 25, 2023
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive CardiologySalim S Virani, Karen Aspry, Dave L Dixon, et al.
American Journal of Preventive Cardiology|March 27, 2023
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the National Lipid Association and the American Society for Preventive CardiologySalim S Virani, Karen Aspry, Dave L Dixon, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2015
Hypertension in african americans aged 60 to 79 years: statement from the international society of hypertension in blacksBrent M Egan, Veita J Bland, Angela L Brown, et al.
American Journal of Preventive Cardiology|March 14, 2022
Practical, Evidence-Based Approaches to Nutritional Modifications to Reduce Atherosclerotic Cardiovascular Disease: An American Society For Preventive Cardiology Clinical Practice StatementDanielle Belardo, Erin D Michos, Ron Blankstein, et al.
Hypertension (Dallas, Tex. : 1979)|January 22, 2025
Aprocitentan for Blood Pressure Reduction in Black PatientsJohn M Flack, Markus P Schlaich, Michael A Weber, et al.
Journal of Medical Virology|June 13, 2020
Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: A meta-regression and decision tree analysisEman A Toraih, Rami M Elshazli, Mohammad H Hussein, et al.
Hypertension (Dallas, Tex. : 1979)|August 5, 2024
Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart AssociationJennifer L Cluett, Olivia Blazek, Angela L Brown, et al.
American Journal of Preventive Cardiology|September 6, 2021
Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statementErin D Michos, Tina K Reddy, Martha Gulati, et al.
Ethnicity & Disease|November 25, 2003
For the patient. What is the Metabolic Syndrome and why is it important?W Dallas Hall, Luther T Clark, Nanette K Wenger, et al.
The American Journal of Cardiology|January 31, 2006
Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trialKeith C Ferdinand, Luther T Clark, Karol E Watson, et al.
Pageof 29

Showing results (231-240 of 287) with videos related to

Sort By:
Pageof 29
Journal of Clinical Lipidology|March 25, 2023
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive CardiologySalim S Virani, Karen Aspry, Dave L Dixon, et al.
American Journal of Preventive Cardiology|March 27, 2023
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the National Lipid Association and the American Society for Preventive CardiologySalim S Virani, Karen Aspry, Dave L Dixon, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2015
Hypertension in african americans aged 60 to 79 years: statement from the international society of hypertension in blacksBrent M Egan, Veita J Bland, Angela L Brown, et al.
American Journal of Preventive Cardiology|March 14, 2022
Practical, Evidence-Based Approaches to Nutritional Modifications to Reduce Atherosclerotic Cardiovascular Disease: An American Society For Preventive Cardiology Clinical Practice StatementDanielle Belardo, Erin D Michos, Ron Blankstein, et al.
Hypertension (Dallas, Tex. : 1979)|January 22, 2025
Aprocitentan for Blood Pressure Reduction in Black PatientsJohn M Flack, Markus P Schlaich, Michael A Weber, et al.
Journal of Medical Virology|June 13, 2020
Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: A meta-regression and decision tree analysisEman A Toraih, Rami M Elshazli, Mohammad H Hussein, et al.
Hypertension (Dallas, Tex. : 1979)|August 5, 2024
Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart AssociationJennifer L Cluett, Olivia Blazek, Angela L Brown, et al.
American Journal of Preventive Cardiology|September 6, 2021
Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statementErin D Michos, Tina K Reddy, Martha Gulati, et al.
Ethnicity & Disease|November 25, 2003
For the patient. What is the Metabolic Syndrome and why is it important?W Dallas Hall, Luther T Clark, Nanette K Wenger, et al.
The American Journal of Cardiology|January 31, 2006
Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trialKeith C Ferdinand, Luther T Clark, Karol E Watson, et al.
Pageof 29